ALEXANDER LEVITZKI

Person

BURLA, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Chimeric proteins for targeting dsRNA
- Patent number 11,912,747
- Issue date Feb 27, 2024
- TARGIMMUNE THERAPEUTICS AG
- Alexander Levitzki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cancer
- Patent number 11,298,376
- Issue date Apr 12, 2022
- TARGIMMUNE THERAPEUTICS AG
- Alex Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric proteins for targeting dsRNA
- Patent number 11,230,580
- Issue date Jan 25, 2022
- TARGIMMUNE THERAPEUTICS AG
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyplex of double-stranded RNA and polymeric conjugate
- Patent number 10,543,232
- Issue date Jan 28, 2020
- TARGIMMUNE THERAPEUTICS AG
- Alex Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polyethyleneimine polyethyleneglycol vectors
- Patent number 10,278,991
- Issue date May 7, 2019
- TARGIMMUNE THERAPEUTICS AG
- Alex Levitzki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1R signaling pathway inhibitors useful in the treatment of neur...
- Patent number 10,188,659
- Issue date Jan 29, 2019
- Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
- Hadas Reuveni
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IGF-1R signaling pathway inhibitors useful in the treatment of neur...
- Patent number 9,770,454
- Issue date Sep 26, 2017
- Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
- Hadas Reuveni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 9,096,499
- Issue date Aug 4, 2015
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the t...
- Patent number 9,073,880
- Issue date Jul 7, 2015
- Yissum Research Development Company of the Hebrew University of Jeruselem Ltd.
- Hadas Reuveni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGFR-homing double-stranded RNA vector for systemic cancer treatment
- Patent number 9,006,406
- Issue date Apr 14, 2015
- Alexander Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Quinazoline-based T cell proliferation inhibitors
- Patent number 8,759,363
- Issue date Jun 24, 2014
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 8,648,102
- Issue date Feb 11, 2014
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of protein kinase signaling
- Patent number 8,637,575
- Issue date Jan 28, 2014
- Novotyr Therapeutics Ltd.
- Hadas Reuveni
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of protein kinase signaling
- Patent number 8,536,227
- Issue date Sep 17, 2013
- Novotyr Therapeutics Ltd.
- Hadas Reuveni
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyalkylene glycol derivatives of inhibitors of epidermal growth f...
- Patent number 8,461,166
- Issue date Jun 11, 2013
- Hadasit Medical Research Services and Development Ltd.
- Eyal Mishani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted double stranded RNA mediated cell killing
- Patent number 8,372,818
- Issue date Feb 12, 2013
- Yissum Research Development Company of the Hebrew Univiersity of Jerusalem
- Alexei Shir
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 8,119,827
- Issue date Feb 21, 2012
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase modulators and therapeutic uses thereof
- Patent number 8,058,309
- Issue date Nov 15, 2011
- Novotyr Therapeutics Ltd.
- Hadas Reuveni
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective killing of cells by activation of double-stranded RNA dep...
- Patent number 8,044,032
- Issue date Oct 25, 2011
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexei Shir
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cell line comprising vector encoding truncated FLK-1 receptor
- Patent number 7,964,399
- Issue date Jun 21, 2011
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted double stranded RNA mediated cell killing
- Patent number 7,927,792
- Issue date Apr 19, 2011
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Alexei Shir
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 7,745,468
- Issue date Jun 29, 2010
- Board of Regents, University of Texas Systems The
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and compositions for inhibiting cell proliferative disorders
- Patent number 7,217,737
- Issue date May 15, 2007
- Yissum Research and Development Company of the Hebrew University of Jerusalem
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiolabeled irreversible inhibitors of epidermal growth factor rec...
- Patent number 7,172,749
- Issue date Feb 6, 2007
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase inhibitors
- Patent number 6,949,565
- Issue date Sep 27, 2005
- Develogen Israel Ltd.
- Nurit Livnah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Truncated Flk-1 receptor protein, methods of use and a recombinant...
- Patent number 6,872,699
- Issue date Mar 29, 2005
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PDGF receptor kinase inhibitory compounds, their preparation, purif...
- Patent number 6,673,798
- Issue date Jan 6, 2004
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting cell proliferative disorders
- Patent number 6,596,878
- Issue date Jul 22, 2003
- Yissum Research & Development Company of the Hebrew University
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiolabeled irreversible inhibitors of epidermal growth factor rec...
- Patent number 6,562,319
- Issue date May 13, 2003
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Eyal Mishani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising tyrphostins
- Patent number 6,426,366
- Issue date Jul 30, 2002
- Notox, Ltd.
- Abraham Novogrodsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF TREATING CANCER
- Publication number 20220339189
- Publication date Oct 27, 2022
- TARGIMMUNE THERAPEUTICS AG
- Alex Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC PROTEINS FOR TARGETING dsRNA
- Publication number 20220213158
- Publication date Jul 7, 2022
- TARGIMMUNE THERAPEUTICS AG
- Alexander LEVITZKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPY FOR THE TREATMENT OF CANCER
- Publication number 20220175814
- Publication date Jun 9, 2022
- TARGIMMUNE THERAPEUTICS AG
- Derrick BROKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN
- Publication number 20200407453
- Publication date Dec 31, 2020
- TARGIMMUNE THERAPEUTICS AG
- Alexander LEVITZKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CASTRATION RESISTANT PROSTATE CANCER
- Publication number 20200230248
- Publication date Jul 23, 2020
- TARGIMMUNE THERAPEUTICS AG
- Esteban POMBO-VILLAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING CANCER
- Publication number 20190262395
- Publication date Aug 29, 2019
- TARGIMMUNE THERAPEUTICS AG
- Alex Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC PROTEINS FOR TARGETING dsRNA
- Publication number 20190194282
- Publication date Jun 27, 2019
- TARGIMMUNE THERAPEUTICS AG
- Alexander LEVITZKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPLEX OF DOUBLE-STRANDED RNA AND POLYMERIC CONJUGATE
- Publication number 20190192563
- Publication date Jun 27, 2019
- TARGIMMUNE THERAPEUTICS AG
- Alex Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC PROTEINS FOR TARGETING dsRNA
- Publication number 20180346596
- Publication date Dec 6, 2018
- Alex Levitzki Management and Holdings, Ltd.
- Alexander LEVITZKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEUR...
- Publication number 20180064725
- Publication date Mar 8, 2018
- Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
- Hadas REUVENI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYETHYLENEIMINE POLYETHYLENEGLYCOL VECTORS
- Publication number 20170072063
- Publication date Mar 16, 2017
- ALEX LEVITZKI MANAGEMENT AND HOLDINGS LTD
- Alex Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEUR...
- Publication number 20160158243
- Publication date Jun 9, 2016
- Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
- Hadas REUVENI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20140329901
- Publication date Nov 6, 2014
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-(2-PHENYLETHENYL) 1,3-BENZODIAZEPINE COMPOUNDS USEFUL FOR THE TRE...
- Publication number 20130274251
- Publication date Oct 17, 2013
- NOVOTYR THERAPEUTICS LTD.
- Hadas Reuveni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE-BASED T CELL PROLIFERATION INHIBITORS
- Publication number 20130109706
- Publication date May 2, 2013
- YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERSALEM LTD.
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20120214850
- Publication date Aug 23, 2012
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF
- Publication number 20120083528
- Publication date Apr 5, 2012
- NOVOTYR THERAPEUTICS LTD.
- Hadas Reuveni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR-HOMING DOUBLE-STRANDED RNA VECTOR FOR SYSTEMIC CANCER TREATMENT
- Publication number 20120021006
- Publication date Jan 26, 2012
- Alexander Levitzki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED DOUBLE STRANDED RNA MEDIATED CELL KILLING
- Publication number 20110177102
- Publication date Jul 21, 2011
- YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
- Alexei SHIR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL MODULATORS OF PROTEIN KINASE SIGNALING
- Publication number 20110105618
- Publication date May 5, 2011
- NOVOTYR THERAPEUTICS LTD.
- Hadas Reuveni
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20110021805
- Publication date Jan 27, 2011
- The Board of Regents of the University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF
- Publication number 20100056635
- Publication date Mar 4, 2010
- Hadas Reuveni
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cell permeable conjugates of peptides for inhibition of protein kin...
- Publication number 20090156507
- Publication date Jun 18, 2009
- CureGenics Ltd.
- Narit Livnah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polyalkylene glycol derivatives of inhibitors of epidermal growth f...
- Publication number 20080056990
- Publication date Mar 6, 2008
- T.K. Signal Ltd.
- Eyal Mishani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell permeable conjugates of peptides for inhibition of protein kin...
- Publication number 20070078092
- Publication date Apr 5, 2007
- Nurit Livnah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective killing of cells by activation of double-stranded RNA dep...
- Publication number 20070036764
- Publication date Feb 15, 2007
- YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
- Alexei Shir
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Targeted double stranded rna mediated cell killing
- Publication number 20070010467
- Publication date Jan 11, 2007
- Alexei Shir
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel irreversible inhibitors of epidermal growth factor receptor t...
- Publication number 20060025430
- Publication date Feb 2, 2006
- Eyal Mishani
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Catechol bioisosteres
- Publication number 20050143430
- Publication date Jun 30, 2005
- Aviv Gazit
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLK-1 is a receptor for vascular endothelial growth factor
- Publication number 20050107321
- Publication date May 19, 2005
- SUGEN, INC. and MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

ALEXANDER LEVITZKI

Person

Patents Grantslast 30 patents

Chimeric proteins for targeting dsRNA

Method of treating cancer

Chimeric proteins for targeting dsRNA

Polyplex of double-stranded RNA and polymeric conjugate

Polyethyleneimine polyethyleneglycol vectors

IGF-1R signaling pathway inhibitors useful in the treatment of neur...

IGF-1R signaling pathway inhibitors useful in the treatment of neur...

Compounds for treatment of cell proliferative diseases

2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the t...

EGFR-homing double-stranded RNA vector for systemic cancer treatment

Quinazoline-based T cell proliferation inhibitors

Compounds for treatment of cell proliferative diseases

Modulators of protein kinase signaling

Modulators of protein kinase signaling

Polyalkylene glycol derivatives of inhibitors of epidermal growth f...

Targeted double stranded RNA mediated cell killing

Compounds for treatment of cell proliferative diseases

Protein kinase modulators and therapeutic uses thereof

Selective killing of cells by activation of double-stranded RNA dep...

Cell line comprising vector encoding truncated FLK-1 receptor

Targeted double stranded RNA mediated cell killing

Compounds for treatment of cell proliferative diseases

Method and compositions for inhibiting cell proliferative disorders

Radiolabeled irreversible inhibitors of epidermal growth factor rec...

Protein kinase inhibitors

Truncated Flk-1 receptor protein, methods of use and a recombinant...

PDGF receptor kinase inhibitory compounds, their preparation, purif...

Methods and compositions for inhibiting cell proliferative disorders

Radiolabeled irreversible inhibitors of epidermal growth factor rec...

Pharmaceutical compositions comprising tyrphostins

Patents Applicationslast 30 patents

METHOD OF TREATING CANCER

CHIMERIC PROTEINS FOR TARGETING dsRNA

IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN

CASTRATION RESISTANT PROSTATE CANCER

METHOD OF TREATING CANCER

CHIMERIC PROTEINS FOR TARGETING dsRNA

POLYPLEX OF DOUBLE-STRANDED RNA AND POLYMERIC CONJUGATE

CHIMERIC PROTEINS FOR TARGETING dsRNA

IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEUR...

POLYETHYLENEIMINE POLYETHYLENEGLYCOL VECTORS

IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEUR...

COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES

2-(2-PHENYLETHENYL) 1,3-BENZODIAZEPINE COMPOUNDS USEFUL FOR THE TRE...

QUINAZOLINE-BASED T CELL PROLIFERATION INHIBITORS

COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES

NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF

EGFR-HOMING DOUBLE-STRANDED RNA VECTOR FOR SYSTEMIC CANCER TREATMENT

TARGETED DOUBLE STRANDED RNA MEDIATED CELL KILLING

NOVEL MODULATORS OF PROTEIN KINASE SIGNALING

COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES

NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF

Cell permeable conjugates of peptides for inhibition of protein kin...

Polyalkylene glycol derivatives of inhibitors of epidermal growth f...

Cell permeable conjugates of peptides for inhibition of protein kin...

Selective killing of cells by activation of double-stranded RNA dep...

Targeted double stranded rna mediated cell killing

Novel irreversible inhibitors of epidermal growth factor receptor t...

Catechol bioisosteres

FLK-1 is a receptor for vascular endothelial growth factor